ArticleJournal of Brown hospital medicine2025
Diffuse Large B Cell Lymphoma presenting as Right Atrial Mass and Cardiac Tamponade.
Article in Journal of Brown hospital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diffuse large B-cell lymphoma (DLBCL) is the most prevalent histologic subtype of non-Hodgkin lymphomas. It usually presents with nodal involvement (cervical, mediastinal, or abdominal), but approximately 30% of patients will exhibit extranodal involvement, with 2-4% presenting as a primary cardiac mass. Multimodal imaging is essential to distinguish these masses from other common benign lesions and to assist in surgical planning. Here, we report a case of DLBCL manifested as a right atrial mass, pericardial effusion, and cardiac tamponade. Transesophageal echocardiogram (TEE) and cardiac magnetic resonance imaging (CMR) were complementary to transthoracic echocardiogram in diagnosing the cardiac neoplasm, with positron emission tomography (PET-CT) aiding in staging and localizing the primary tumor. Biopsy of the cardiac mass or extracardiac involvement confirms the histopathological subtype and guides the treatment. Although primary and secondary cardiac tumors have poor outcomes, early diagnosis and aggressive treatment can influence prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.